Delivery Order SPE2DB24D1021-SPE2DB25FESFM

Award Date 11/26/24
Potential Completion Date 12/18/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTORML. The contract has a firm fixed price with a ceiling value of $6,165.34 and a period of performance through June 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle, valued at $999,999,999.00, that AmerisourceBergen holds with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR medication. The contract has a ceiling value of $9,975.58 and a performance period extending through June 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The contract has a ceiling value of $14,963.34 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, with a ceiling value of $5,586.06 and a period of performance through November 12, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The contract has a firm fixed price ceiling value of $5,586.06 and an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this order as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The contract has a ceiling value of $3,082.67 and a period of performance extending through July 25, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $9,975.58 and a performance period ending on May 19, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The firm-fixed-price contract has a ceiling value of $39,902.24 and a period of performance through June 4, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. The...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, with a ceiling value of $3,082.67 and a completion date of January 27, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a medical product, with a ceiling value of $6,165.34 and a period of performance through June 10, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FESFM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR medication. The contract is a firm-fixed-price delivery order with a ceiling value of $5,779.12 and an ultimate completion date of December 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/25/25, 10:20 AM